Sore Throat Prevention Following Intubation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02682134|
Recruitment Status : Completed
First Posted : February 15, 2016
Last Update Posted : February 15, 2016
|Condition or disease||Intervention/treatment||Phase|
|Sore Throat||Drug: xylocaine Drug: Dexamethasone Drug: Xylocaine and Dexamethasone||Phase 4|
Three groups were divided into: first group received xylocaine gel as endotracheal cuff lubricant,second group received dexamethasone 8 mg intravenously and third group received both( xylocaine and dexamethasone).
The investigator compared between the three groups regarding sore throat in intubated patients and followed them up to 48 hours.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||300 participants|
|Intervention Model:||Single Group Assignment|
|Official Title:||Comparison Between Xylocaine Gel as Endotracheal Cuff Lubricant Versus Dexamethasone 8 mg Intravenously or Both for Sore Throat Prevention Following Intubation: Interventional Study|
|Study Start Date :||November 2015|
|Actual Primary Completion Date :||February 2016|
|Actual Study Completion Date :||February 2016|
Experimental: Xylocaine "X"
Patients received xylocaine gel as lubricant on endotracheal tube
First group were given xylocaine
Other Name: X
Experimental: Dexamethasone "D"
Patients were given dexamethasone 8 mg intravenously
Second group were given Dexamethasone
Other Name: D
Experimental: xylocaine and dexamethasone "XD"
Patients were given both xylocaine gel and dexamethasone 8 mg intravenously
Drug: Xylocaine and Dexamethasone
Third group were given both Xylocaine and Dexamethasone
Other Name: XD
- Comparison in preventing sore throat: xylocaine gel versus dexamethasone or both following intubation. [ Time Frame: 4 months ]Questionnaire follow up in intubated patients.
- Sore throat SCALE [ Time Frame: 4 months ]Sore throat scale from None,mild,moderate till severe.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02682134
|Principal Investigator:||Aboud Aljabari||University of Jordan|